Nitric oxide (NO) is an effector of the innate immune system. The innate immune system is a set of rapid host responses to pathogens. Cells of the innate immune system -macrophages, neutrophils and natural killer cellsuse pattern recognition receptors to recognize molecular patterns associated with pathogens (Medzhitov, 2001 (Darnell et al., 1994) . The interferon signaling pathway can also activate NOS2 transcription.
Transcriptional regulation: interacting transcription factors activate NOS2 transcription LPS-mediated activation of the innate immune pattern recognition receptors stimulates NOS2 mRNA transcription within 2-4 hours, and NOS2 translation within 6 hours. LPS activation of TLR4 leads to phosphorylation of inhibitor of NF-κB kinase (IKK), which phosphorylates the inhibitor of NF-κB (IκB), which releases the transcription factor NF-κB. NF-κB translocates from the cytoplasm to the nucleus, where it interacts with κB elements in the NOS2 5′ flanking region, triggering NOS2 transcription (Xie et al., 1994) . IFN-γ triggers NOS2 transcription by activating the JAK/STAT pathway, leading to synthesis of the transcription factor interferon response factor 1 (IRF-1), which stimulates NOS2 transcription (Kamijo et al., 1994) . IFN-γ also provides a synergistic boost to LPS induction of NOS2 transcription because IRF-1 interacts with NF-κB, altering the conformation of the NOS2 promoter (Saura et al., 1999a) . Scaffolding proteins such as HMG-Y(I) and transcriptional activators such as CBP interact with IRF-1 and NF-κB, forming a multi-subunit complex that increases NOS2 transcription (Perrella et al., 1999) . Other transcription factors, including Stat1α and hypoxia inducible factor-1 (HIF-1), can also regulate NOS2 expression. (Ratovitski et al., 1999) . Although NOS2 is ubiquitylated and phosphorylated, the significance of these post-translational modifications is unknown.
Post

Inhibition of NOS2 expression
Transforming growth factor β (TGF-β) inhibits NOS2 expression through transcriptional, post-transcriptional and post-translational mechanisms (Vodovotz et al., 1993) . TGF-β inhibits NOS2 transcription in part by blocking expression of the scaffolding protein HMG-I(Y). A variety of other signaling molecules, including IL-4, IL-10, IL-13 and macrophage deactivation factor, inhibit NOS2 expression by unknown mechanisms.
NOS2 structure
NOS2 contains a C-terminal reductase domain, which binds NADPH and transfers electrons from NADPH to FAD and then to FMN, and an N-terminal oxygenase domain, which contains a heme and binding sites for arginine, tetrahydrobiopterin and calmodulin. NOS2 utilizes oxygen and electrons from NADPH to oxidize the substrate Larginine into the intermediate OH-Larginine, which is then oxidized into NO and L-citrulline.
In contrast to the other NOS isoforms NOS1 and NOS3, dimeric NOS2 is always active when expressed. Although NOS2 binds calmodulin, NOS2 is independent of intracellular calcium levels, whereas calcium regulates NOS1 and NOS3 activity (Cho et al., 1992) .
The V max of NOS2 is approximately 10-fold greater than the other NOS isoforms; so NOS2 is a high-output NOS compared with the low-output isoforms NOS1 and NOS3.
NO and oxygen radicals NO and superoxide (O2 -) are radical effectors of the innate immune system that can directly inhibit pathogen replication (Nathan and Shiloh, 2000) . Derivatives of NO can also block infections. NO can combine with O2 -to form peroxynitrite anion (ONOO -). NO can also form nitrosothiols, nitrogen dioxide (NO2) and other nitrosating species. Superoxide can form hydrogen peroxide, which in turn can form hypochlorous acid and other oxidants. These reactive nitrogen intermediates and reactive oxygen intermediates can cross bacterial and fungal walls with differing facility, and react with specific pathogen targets (Fang, 1997) .
Anti-bacterial effects of NO
NO is an anti-bacterial effector of the innate immune system (Fang, 1997) . NO can inhibit bacterial DNA synthesis by inhibiting bacterial ribonucleotide reductase. NO can also cause doublestranded breaks (DSBs) in bacterial DNA. NO can modify cysteine residues in bacterial proteins, oxidize bacterial lipids, and interact with heme iron and iron-sulfur clusters in bacterial enzymes. However, it is unclear whether modification of these bacterial targets contributes to the anti-bacterial effects of NO. NO mobilizes zinc in bacteria, which suggests that DNAbinding proteins containing zinc are targets of NO (Schapiro et al., 2003) . It can also can increase the susceptibility of bacteria to oxidative DNA damage by blocking respiration (Woodmansee and Imlay, 2003) . Peroxynitrite can oxidize bacterial lipids and produce nitrotyrosine of bacterial polypeptides, but the biological significance of these modifications is also unclear.
Bacterial defenses against NO
Oxidants activate bacterial defenses. The bacterial protein SoxRS serves as a sensor for NO, and can activate transcription of a set of bacterial genes whose products defend the pathogen from oxidant damage -for example, bacterial superoxide dismutase (SOD). The bacterial protein OxyR can be modified and activated by hydrogen peroxide or NO, and directs the transcription of bacterial genes such as alkyl hydroperoxide reductase (AHP), which confers resistance to peroxynitrite, and catalase (CAT), which deactivates hydrogen peroxide (Bryk et al., 2000; Hausladen et al., 1996) . The bacterial protein ferric uptake regulatory protein (Fur) also serves as an NO sensor. Fur is an iron-containing bacterial transcription factor that normally represses a set of nitrosative stress response genes. NO inactivates Fur by interacting with its iron cofactor, permitting expression of genes protective against oxidative stress (Crawford and Goldberg, 1998; D'Autreaux et al., 2002) . One bacterial gene regulated by Fur encodes a flavohemoglobin that can detoxify NO, protecting pathogens from NO (Gardner et al., 1998; Hausladen et al., 2001 ). Thus multiple signaling pathways defend bacteria against NO. (Saura et al., 1999b; Zaragoza et al., 1998) .
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